Association between concomitant psychiatric drug use,and patients’ beliefs about and persistence with chronic cardiovascular medication
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F12%3A00006050" target="_blank" >RIV/00023884:_____/12:00006050 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1111/ijcp.12544" target="_blank" >http://dx.doi.org/10.1111/ijcp.12544</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/ijcp.12544" target="_blank" >10.1111/ijcp.12544</a>
Alternative languages
Result language
angličtina
Original language name
Association between concomitant psychiatric drug use,and patients’ beliefs about and persistence with chronic cardiovascular medication
Original language description
Objective: Psychiatric disorders are associated with an increased risk of cardiovascular diseases and may result in additional risk of non-adherence. No data on the influence of concomitant psychiatric drug use on patients’ beliefs and persistence related to cardiovascular medication are available. The objective of this study was to assess to what extent the use of concomitant psychiatric drugs is associated with patients’ beliefs about and persistence with chronic cardiovascular medication. Methods: An observational study in patients using cardiovascular medication was conducted. A mailed questionnaire containing socio-demographical questions and a measure of beliefs about medication (Beliefs about Medicines Questionnaire – specific) was sent to patients selected from fifteen participating pharmacies. Persistence was evaluated based on pharmacy records. Results: Of the 1547 included patients, 551 responded to key questions in the questionnaire and were included for beliefs about medication analysis. In concomitant users of psychiatric drugs significantly higher necessity (17.0 vs. 16.0) and higher concerns (14.3 vs. 13.3), as well as higher proportion of ambivalent (34.5% vs. 25.6%) and lower proportion of indifferent patients (24.1% vs. 33.0%) were found compared with non-users (p < 0.05). 65.2% (n = 1009) of patients were persistent on all their cardiovascular drugs. There was no significant association between concomitant use of psychiatric drugs and non-persistence (OR = 1.2; 95% CI 0.9–1.5). Conclusion: Concomitant use of psychiatric drugs was found to be associated with increased beliefs about the necessity of and concerns about cardiovascular medication. Clinicians caring for cardiovascular patients should give additional attention to identifying patients’ beliefs about medication among those concomitantly using psychiatric drugs.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
International Journal of Clinical Practice
ISSN
1742-1241
e-ISSN
—
Volume of the periodical
69
Issue of the periodical within the volume
3
Country of publishing house
GB - UNITED KINGDOM
Number of pages
8
Pages from-to
328-335
UT code for WoS article
000350307200010
EID of the result in the Scopus database
2-s2.0-84988241338